ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vitro Diagnostic Active Ingredients Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-17G19434
Home | Market Reports | Health| Reproductive Health
Global In Vitro Diagnostic Active Ingredients Market Research Report 2025
BUY CHAPTERS

Global In Vitro Diagnostic Active Ingredients Market Research Report 2025

Code: QYRE-Auto-17G19434
Report
April 2025
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Roche
Medix Biochemica
Thermo Fisher
JSR Life Sciences (MBL)
Hytest
BBI Solution
Meridian
Biosynth
Creative Diagnostics
Leinco Technologies
SERION Immunologics
MP Biomedicals
Autobio Diagnostics
Fapon Biotech
Sino Biological
Nanjing Vazyme Biotech
GenScript ProBio
Operon
ABclonal
Bioporto
Glentham Life Sciences
ImmunoDiagnostics
PRAHAS Healthcare
Promega
Rockland Immunochemicals

In Vitro Diagnostic Active Ingredients Market Size

The global market for In Vitro Diagnostic Active Ingredients was valued at US$ 1440 million in the year 2024 and is projected to reach a revised size of US$ 2095 million by 2031, growing at a CAGR of 5.5% during the forecast period.

In Vitro Diagnostic Active Ingredients Market

In Vitro Diagnostic Active Ingredients Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on In Vitro Diagnostic Active Ingredients competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In vitro diagnostic (IVD) active ingredients are the key biological or chemical components used in diagnostic tests performed outside the human body—typically in laboratories or point-of-care settings—to detect diseases, conditions, or infections. These ingredients include enzymes, antibodies, antigens, nucleic acids, and other reagents that interact with patient samples (like blood, saliva, or urine) to identify the presence of specific biomarkers or pathogens. They play a critical role in the accuracy and reliability of diagnostic tests, supporting early detection, disease monitoring, and treatment decisions across a wide range of medical fields.
North American market for In Vitro Diagnostic Active Ingredients is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for In Vitro Diagnostic Active Ingredients is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of In Vitro Diagnostic Active Ingredients include Merck, Roche, Medix Biochemica, Thermo Fisher, JSR Life Sciences (MBL), HyTest, BBI Solution, Meridian, Biosynth, Creative Diagnostics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostic Active Ingredients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostic Active Ingredients.
The In Vitro Diagnostic Active Ingredients market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Diagnostic Active Ingredients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Diagnostic Active Ingredients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of In Vitro Diagnostic Active Ingredients Market Report

Report Metric Details
Report Name In Vitro Diagnostic Active Ingredients Market
Accounted market size in year US$ 1440 million
Forecasted market size in 2031 US$ 2095 million
CAGR 5.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
Segment by Application
  • Diabetes
  • Infectious Diseases
  • Oncology
  • Heart Disease
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Roche, Medix Biochemica, Thermo Fisher, JSR Life Sciences (MBL), HyTest, BBI Solution, Meridian, Biosynth, Creative Diagnostics, Leinco Technologies, SERION Immunologics, MP Biomedicals, Autobio Diagnostics, Fapon Biotech, Sino Biological, Nanjing Vazyme Biotech, GenScript ProBio, OPERON, ABclonal, BioPorto, Glentham Life Sciences, ImmunoDiagnostics, Prahas Healthcare, Promega, Rockland Immunochemicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of In Vitro Diagnostic Active Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of In Vitro Diagnostic Active Ingredients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is In Vitro Diagnostic Active Ingredients Market growing?

Ans: The In Vitro Diagnostic Active Ingredients Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the In Vitro Diagnostic Active Ingredients Market size in 2031?

Ans: The In Vitro Diagnostic Active Ingredients Market size in 2031 will be US$ 2095 million.

Who are the main players in the In Vitro Diagnostic Active Ingredients Market report?

Ans: The main players in the In Vitro Diagnostic Active Ingredients Market are Merck, Roche, Medix Biochemica, Thermo Fisher, JSR Life Sciences (MBL), HyTest, BBI Solution, Meridian, Biosynth, Creative Diagnostics, Leinco Technologies, SERION Immunologics, MP Biomedicals, Autobio Diagnostics, Fapon Biotech, Sino Biological, Nanjing Vazyme Biotech, GenScript ProBio, OPERON, ABclonal, BioPorto, Glentham Life Sciences, ImmunoDiagnostics, Prahas Healthcare, Promega, Rockland Immunochemicals

What are the Application segmentation covered in the In Vitro Diagnostic Active Ingredients Market report?

Ans: The Applications covered in the In Vitro Diagnostic Active Ingredients Market report are Diabetes, Infectious Diseases, Oncology, Heart Disease, Others

What are the Type segmentation covered in the In Vitro Diagnostic Active Ingredients Market report?

Ans: The Types covered in the In Vitro Diagnostic Active Ingredients Market report are Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

1 In Vitro Diagnostic Active Ingredients Market Overview
1.1 Product Definition
1.2 In Vitro Diagnostic Active Ingredients by Type
1.2.1 Global In Vitro Diagnostic Active Ingredients Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibodies
1.2.4 Recombinant Antibodies
1.3 In Vitro Diagnostic Active Ingredients by Application
1.3.1 Global In Vitro Diagnostic Active Ingredients Market Value by Application (2024 VS 2031)
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology
1.3.5 Heart Disease
1.3.6 Others
1.4 Global In Vitro Diagnostic Active Ingredients Market Size Estimates and Forecasts
1.4.1 Global In Vitro Diagnostic Active Ingredients Revenue 2020-2031
1.4.2 Global In Vitro Diagnostic Active Ingredients Sales 2020-2031
1.4.3 Global In Vitro Diagnostic Active Ingredients Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 In Vitro Diagnostic Active Ingredients Market Competition by Manufacturers
2.1 Global In Vitro Diagnostic Active Ingredients Sales Market Share by Manufacturers (2020-2025)
2.2 Global In Vitro Diagnostic Active Ingredients Revenue Market Share by Manufacturers (2020-2025)
2.3 Global In Vitro Diagnostic Active Ingredients Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of In Vitro Diagnostic Active Ingredients, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of In Vitro Diagnostic Active Ingredients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of In Vitro Diagnostic Active Ingredients, Product Type & Application
2.7 Global Key Manufacturers of In Vitro Diagnostic Active Ingredients, Date of Enter into This Industry
2.8 Global In Vitro Diagnostic Active Ingredients Market Competitive Situation and Trends
2.8.1 Global In Vitro Diagnostic Active Ingredients Market Concentration Rate
2.8.2 The Global 5 and 10 Largest In Vitro Diagnostic Active Ingredients Players Market Share by Revenue
2.8.3 Global In Vitro Diagnostic Active Ingredients Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global In Vitro Diagnostic Active Ingredients Market Scenario by Region
3.1 Global In Vitro Diagnostic Active Ingredients Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global In Vitro Diagnostic Active Ingredients Sales by Region: 2020-2031
3.2.1 Global In Vitro Diagnostic Active Ingredients Sales by Region: 2020-2025
3.2.2 Global In Vitro Diagnostic Active Ingredients Sales by Region: 2026-2031
3.3 Global In Vitro Diagnostic Active Ingredients Revenue by Region: 2020-2031
3.3.1 Global In Vitro Diagnostic Active Ingredients Revenue by Region: 2020-2025
3.3.2 Global In Vitro Diagnostic Active Ingredients Revenue by Region: 2026-2031
3.4 North America In Vitro Diagnostic Active Ingredients Market Facts & Figures by Country
3.4.1 North America In Vitro Diagnostic Active Ingredients Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America In Vitro Diagnostic Active Ingredients Sales by Country (2020-2031)
3.4.3 North America In Vitro Diagnostic Active Ingredients Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe In Vitro Diagnostic Active Ingredients Market Facts & Figures by Country
3.5.1 Europe In Vitro Diagnostic Active Ingredients Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe In Vitro Diagnostic Active Ingredients Sales by Country (2020-2031)
3.5.3 Europe In Vitro Diagnostic Active Ingredients Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific In Vitro Diagnostic Active Ingredients Market Facts & Figures by Region
3.6.1 Asia Pacific In Vitro Diagnostic Active Ingredients Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific In Vitro Diagnostic Active Ingredients Sales by Region (2020-2031)
3.6.3 Asia Pacific In Vitro Diagnostic Active Ingredients Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America In Vitro Diagnostic Active Ingredients Market Facts & Figures by Country
3.7.1 Latin America In Vitro Diagnostic Active Ingredients Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America In Vitro Diagnostic Active Ingredients Sales by Country (2020-2031)
3.7.3 Latin America In Vitro Diagnostic Active Ingredients Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa In Vitro Diagnostic Active Ingredients Market Facts & Figures by Country
3.8.1 Middle East and Africa In Vitro Diagnostic Active Ingredients Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa In Vitro Diagnostic Active Ingredients Sales by Country (2020-2031)
3.8.3 Middle East and Africa In Vitro Diagnostic Active Ingredients Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global In Vitro Diagnostic Active Ingredients Sales by Type (2020-2031)
4.1.1 Global In Vitro Diagnostic Active Ingredients Sales by Type (2020-2025)
4.1.2 Global In Vitro Diagnostic Active Ingredients Sales by Type (2026-2031)
4.1.3 Global In Vitro Diagnostic Active Ingredients Sales Market Share by Type (2020-2031)
4.2 Global In Vitro Diagnostic Active Ingredients Revenue by Type (2020-2031)
4.2.1 Global In Vitro Diagnostic Active Ingredients Revenue by Type (2020-2025)
4.2.2 Global In Vitro Diagnostic Active Ingredients Revenue by Type (2026-2031)
4.2.3 Global In Vitro Diagnostic Active Ingredients Revenue Market Share by Type (2020-2031)
4.3 Global In Vitro Diagnostic Active Ingredients Price by Type (2020-2031)
5 Segment by Application
5.1 Global In Vitro Diagnostic Active Ingredients Sales by Application (2020-2031)
5.1.1 Global In Vitro Diagnostic Active Ingredients Sales by Application (2020-2025)
5.1.2 Global In Vitro Diagnostic Active Ingredients Sales by Application (2026-2031)
5.1.3 Global In Vitro Diagnostic Active Ingredients Sales Market Share by Application (2020-2031)
5.2 Global In Vitro Diagnostic Active Ingredients Revenue by Application (2020-2031)
5.2.1 Global In Vitro Diagnostic Active Ingredients Revenue by Application (2020-2025)
5.2.2 Global In Vitro Diagnostic Active Ingredients Revenue by Application (2026-2031)
5.2.3 Global In Vitro Diagnostic Active Ingredients Revenue Market Share by Application (2020-2031)
5.3 Global In Vitro Diagnostic Active Ingredients Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck In Vitro Diagnostic Active Ingredients Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche In Vitro Diagnostic Active Ingredients Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Medix Biochemica
6.3.1 Medix Biochemica Company Information
6.3.2 Medix Biochemica Description and Business Overview
6.3.3 Medix Biochemica In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medix Biochemica In Vitro Diagnostic Active Ingredients Product Portfolio
6.3.5 Medix Biochemica Recent Developments/Updates
6.4 Thermo Fisher
6.4.1 Thermo Fisher Company Information
6.4.2 Thermo Fisher Description and Business Overview
6.4.3 Thermo Fisher In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher In Vitro Diagnostic Active Ingredients Product Portfolio
6.4.5 Thermo Fisher Recent Developments/Updates
6.5 JSR Life Sciences (MBL)
6.5.1 JSR Life Sciences (MBL) Company Information
6.5.2 JSR Life Sciences (MBL) Description and Business Overview
6.5.3 JSR Life Sciences (MBL) In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.5.4 JSR Life Sciences (MBL) In Vitro Diagnostic Active Ingredients Product Portfolio
6.5.5 JSR Life Sciences (MBL) Recent Developments/Updates
6.6 HyTest
6.6.1 HyTest Company Information
6.6.2 HyTest Description and Business Overview
6.6.3 HyTest In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HyTest In Vitro Diagnostic Active Ingredients Product Portfolio
6.6.5 HyTest Recent Developments/Updates
6.7 BBI Solution
6.7.1 BBI Solution Company Information
6.7.2 BBI Solution Description and Business Overview
6.7.3 BBI Solution In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BBI Solution In Vitro Diagnostic Active Ingredients Product Portfolio
6.7.5 BBI Solution Recent Developments/Updates
6.8 Meridian
6.8.1 Meridian Company Information
6.8.2 Meridian Description and Business Overview
6.8.3 Meridian In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Meridian In Vitro Diagnostic Active Ingredients Product Portfolio
6.8.5 Meridian Recent Developments/Updates
6.9 Biosynth
6.9.1 Biosynth Company Information
6.9.2 Biosynth Description and Business Overview
6.9.3 Biosynth In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biosynth In Vitro Diagnostic Active Ingredients Product Portfolio
6.9.5 Biosynth Recent Developments/Updates
6.10 Creative Diagnostics
6.10.1 Creative Diagnostics Company Information
6.10.2 Creative Diagnostics Description and Business Overview
6.10.3 Creative Diagnostics In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Creative Diagnostics In Vitro Diagnostic Active Ingredients Product Portfolio
6.10.5 Creative Diagnostics Recent Developments/Updates
6.11 Leinco Technologies
6.11.1 Leinco Technologies Company Information
6.11.2 Leinco Technologies Description and Business Overview
6.11.3 Leinco Technologies In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Leinco Technologies In Vitro Diagnostic Active Ingredients Product Portfolio
6.11.5 Leinco Technologies Recent Developments/Updates
6.12 SERION Immunologics
6.12.1 SERION Immunologics Company Information
6.12.2 SERION Immunologics Description and Business Overview
6.12.3 SERION Immunologics In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.12.4 SERION Immunologics In Vitro Diagnostic Active Ingredients Product Portfolio
6.12.5 SERION Immunologics Recent Developments/Updates
6.13 MP Biomedicals
6.13.1 MP Biomedicals Company Information
6.13.2 MP Biomedicals Description and Business Overview
6.13.3 MP Biomedicals In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.13.4 MP Biomedicals In Vitro Diagnostic Active Ingredients Product Portfolio
6.13.5 MP Biomedicals Recent Developments/Updates
6.14 Autobio Diagnostics
6.14.1 Autobio Diagnostics Company Information
6.14.2 Autobio Diagnostics Description and Business Overview
6.14.3 Autobio Diagnostics In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Autobio Diagnostics In Vitro Diagnostic Active Ingredients Product Portfolio
6.14.5 Autobio Diagnostics Recent Developments/Updates
6.15 Fapon Biotech
6.15.1 Fapon Biotech Company Information
6.15.2 Fapon Biotech Description and Business Overview
6.15.3 Fapon Biotech In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Fapon Biotech In Vitro Diagnostic Active Ingredients Product Portfolio
6.15.5 Fapon Biotech Recent Developments/Updates
6.16 Sino Biological
6.16.1 Sino Biological Company Information
6.16.2 Sino Biological Description and Business Overview
6.16.3 Sino Biological In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Sino Biological In Vitro Diagnostic Active Ingredients Product Portfolio
6.16.5 Sino Biological Recent Developments/Updates
6.17 Nanjing Vazyme Biotech
6.17.1 Nanjing Vazyme Biotech Company Information
6.17.2 Nanjing Vazyme Biotech Description and Business Overview
6.17.3 Nanjing Vazyme Biotech In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Nanjing Vazyme Biotech In Vitro Diagnostic Active Ingredients Product Portfolio
6.17.5 Nanjing Vazyme Biotech Recent Developments/Updates
6.18 GenScript ProBio
6.18.1 GenScript ProBio Company Information
6.18.2 GenScript ProBio Description and Business Overview
6.18.3 GenScript ProBio In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.18.4 GenScript ProBio In Vitro Diagnostic Active Ingredients Product Portfolio
6.18.5 GenScript ProBio Recent Developments/Updates
6.19 OPERON
6.19.1 OPERON Company Information
6.19.2 OPERON Description and Business Overview
6.19.3 OPERON In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.19.4 OPERON In Vitro Diagnostic Active Ingredients Product Portfolio
6.19.5 OPERON Recent Developments/Updates
6.20 ABclonal
6.20.1 ABclonal Company Information
6.20.2 ABclonal Description and Business Overview
6.20.3 ABclonal In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.20.4 ABclonal In Vitro Diagnostic Active Ingredients Product Portfolio
6.20.5 ABclonal Recent Developments/Updates
6.21 BioPorto
6.21.1 BioPorto Company Information
6.21.2 BioPorto Description and Business Overview
6.21.3 BioPorto In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.21.4 BioPorto In Vitro Diagnostic Active Ingredients Product Portfolio
6.21.5 BioPorto Recent Developments/Updates
6.22 Glentham Life Sciences
6.22.1 Glentham Life Sciences Company Information
6.22.2 Glentham Life Sciences Description and Business Overview
6.22.3 Glentham Life Sciences In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Glentham Life Sciences In Vitro Diagnostic Active Ingredients Product Portfolio
6.22.5 Glentham Life Sciences Recent Developments/Updates
6.23 ImmunoDiagnostics
6.23.1 ImmunoDiagnostics Company Information
6.23.2 ImmunoDiagnostics Description and Business Overview
6.23.3 ImmunoDiagnostics In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.23.4 ImmunoDiagnostics In Vitro Diagnostic Active Ingredients Product Portfolio
6.23.5 ImmunoDiagnostics Recent Developments/Updates
6.24 Prahas Healthcare
6.24.1 Prahas Healthcare Company Information
6.24.2 Prahas Healthcare Description and Business Overview
6.24.3 Prahas Healthcare In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Prahas Healthcare In Vitro Diagnostic Active Ingredients Product Portfolio
6.24.5 Prahas Healthcare Recent Developments/Updates
6.25 Promega
6.25.1 Promega Company Information
6.25.2 Promega Description and Business Overview
6.25.3 Promega In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Promega In Vitro Diagnostic Active Ingredients Product Portfolio
6.25.5 Promega Recent Developments/Updates
6.26 Rockland Immunochemicals
6.26.1 Rockland Immunochemicals Company Information
6.26.2 Rockland Immunochemicals Description and Business Overview
6.26.3 Rockland Immunochemicals In Vitro Diagnostic Active Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Rockland Immunochemicals In Vitro Diagnostic Active Ingredients Product Portfolio
6.26.5 Rockland Immunochemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 In Vitro Diagnostic Active Ingredients Industry Chain Analysis
7.2 In Vitro Diagnostic Active Ingredients Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 In Vitro Diagnostic Active Ingredients Production Mode & Process Analysis
7.4 In Vitro Diagnostic Active Ingredients Sales and Marketing
7.4.1 In Vitro Diagnostic Active Ingredients Sales Channels
7.4.2 In Vitro Diagnostic Active Ingredients Distributors
7.5 In Vitro Diagnostic Active Ingredients Customer Analysis
8 In Vitro Diagnostic Active Ingredients Market Dynamics
8.1 In Vitro Diagnostic Active Ingredients Industry Trends
8.2 In Vitro Diagnostic Active Ingredients Market Drivers
8.3 In Vitro Diagnostic Active Ingredients Market Challenges
8.4 In Vitro Diagnostic Active Ingredients Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Roche
Medix Biochemica
Thermo Fisher
JSR Life Sciences (MBL)
Hytest
BBI Solution
Meridian
Biosynth
Creative Diagnostics
Leinco Technologies
SERION Immunologics
MP Biomedicals
Autobio Diagnostics
Fapon Biotech
Sino Biological
Nanjing Vazyme Biotech
GenScript ProBio
Operon
ABclonal
Bioporto
Glentham Life Sciences
ImmunoDiagnostics
PRAHAS Healthcare
Promega
Rockland Immunochemicals
List of Tables
 Table 1. Global In Vitro Diagnostic Active Ingredients Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global In Vitro Diagnostic Active Ingredients Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global In Vitro Diagnostic Active Ingredients Market Competitive Situation by Manufacturers in 2024
 Table 4. Global In Vitro Diagnostic Active Ingredients Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global In Vitro Diagnostic Active Ingredients Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global In Vitro Diagnostic Active Ingredients Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global In Vitro Diagnostic Active Ingredients Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market In Vitro Diagnostic Active Ingredients Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of In Vitro Diagnostic Active Ingredients, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of In Vitro Diagnostic Active Ingredients, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of In Vitro Diagnostic Active Ingredients, Product Type & Application
 Table 12. Global Key Manufacturers of In Vitro Diagnostic Active Ingredients, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global In Vitro Diagnostic Active Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostic Active Ingredients as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global In Vitro Diagnostic Active Ingredients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global In Vitro Diagnostic Active Ingredients Sales by Region (2020-2025) & (Units)
 Table 18. Global In Vitro Diagnostic Active Ingredients Sales Market Share by Region (2020-2025)
 Table 19. Global In Vitro Diagnostic Active Ingredients Sales by Region (2026-2031) & (Units)
 Table 20. Global In Vitro Diagnostic Active Ingredients Sales Market Share by Region (2026-2031)
 Table 21. Global In Vitro Diagnostic Active Ingredients Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global In Vitro Diagnostic Active Ingredients Revenue Market Share by Region (2020-2025)
 Table 23. Global In Vitro Diagnostic Active Ingredients Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global In Vitro Diagnostic Active Ingredients Revenue Market Share by Region (2026-2031)
 Table 25. North America In Vitro Diagnostic Active Ingredients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America In Vitro Diagnostic Active Ingredients Sales by Country (2020-2025) & (Units)
 Table 27. North America In Vitro Diagnostic Active Ingredients Sales by Country (2026-2031) & (Units)
 Table 28. North America In Vitro Diagnostic Active Ingredients Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America In Vitro Diagnostic Active Ingredients Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe In Vitro Diagnostic Active Ingredients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe In Vitro Diagnostic Active Ingredients Sales by Country (2020-2025) & (Units)
 Table 32. Europe In Vitro Diagnostic Active Ingredients Sales by Country (2026-2031) & (Units)
 Table 33. Europe In Vitro Diagnostic Active Ingredients Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe In Vitro Diagnostic Active Ingredients Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific In Vitro Diagnostic Active Ingredients Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific In Vitro Diagnostic Active Ingredients Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific In Vitro Diagnostic Active Ingredients Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific In Vitro Diagnostic Active Ingredients Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific In Vitro Diagnostic Active Ingredients Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America In Vitro Diagnostic Active Ingredients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America In Vitro Diagnostic Active Ingredients Sales by Country (2020-2025) & (Units)
 Table 42. Latin America In Vitro Diagnostic Active Ingredients Sales by Country (2026-2031) & (Units)
 Table 43. Latin America In Vitro Diagnostic Active Ingredients Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America In Vitro Diagnostic Active Ingredients Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa In Vitro Diagnostic Active Ingredients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa In Vitro Diagnostic Active Ingredients Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa In Vitro Diagnostic Active Ingredients Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa In Vitro Diagnostic Active Ingredients Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa In Vitro Diagnostic Active Ingredients Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global In Vitro Diagnostic Active Ingredients Sales (Units) by Type (2020-2025)
 Table 51. Global In Vitro Diagnostic Active Ingredients Sales (Units) by Type (2026-2031)
 Table 52. Global In Vitro Diagnostic Active Ingredients Sales Market Share by Type (2020-2025)
 Table 53. Global In Vitro Diagnostic Active Ingredients Sales Market Share by Type (2026-2031)
 Table 54. Global In Vitro Diagnostic Active Ingredients Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global In Vitro Diagnostic Active Ingredients Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global In Vitro Diagnostic Active Ingredients Revenue Market Share by Type (2020-2025)
 Table 57. Global In Vitro Diagnostic Active Ingredients Revenue Market Share by Type (2026-2031)
 Table 58. Global In Vitro Diagnostic Active Ingredients Price (US$/Unit) by Type (2020-2025)
 Table 59. Global In Vitro Diagnostic Active Ingredients Price (US$/Unit) by Type (2026-2031)
 Table 60. Global In Vitro Diagnostic Active Ingredients Sales (Units) by Application (2020-2025)
 Table 61. Global In Vitro Diagnostic Active Ingredients Sales (Units) by Application (2026-2031)
 Table 62. Global In Vitro Diagnostic Active Ingredients Sales Market Share by Application (2020-2025)
 Table 63. Global In Vitro Diagnostic Active Ingredients Sales Market Share by Application (2026-2031)
 Table 64. Global In Vitro Diagnostic Active Ingredients Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global In Vitro Diagnostic Active Ingredients Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global In Vitro Diagnostic Active Ingredients Revenue Market Share by Application (2020-2025)
 Table 67. Global In Vitro Diagnostic Active Ingredients Revenue Market Share by Application (2026-2031)
 Table 68. Global In Vitro Diagnostic Active Ingredients Price (US$/Unit) by Application (2020-2025)
 Table 69. Global In Vitro Diagnostic Active Ingredients Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck In Vitro Diagnostic Active Ingredients Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Roche Company Information
 Table 76. Roche Description and Business Overview
 Table 77. Roche In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Roche In Vitro Diagnostic Active Ingredients Product
 Table 79. Roche Recent Developments/Updates
 Table 80. Medix Biochemica Company Information
 Table 81. Medix Biochemica Description and Business Overview
 Table 82. Medix Biochemica In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Medix Biochemica In Vitro Diagnostic Active Ingredients Product
 Table 84. Medix Biochemica Recent Developments/Updates
 Table 85. Thermo Fisher Company Information
 Table 86. Thermo Fisher Description and Business Overview
 Table 87. Thermo Fisher In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Thermo Fisher In Vitro Diagnostic Active Ingredients Product
 Table 89. Thermo Fisher Recent Developments/Updates
 Table 90. JSR Life Sciences (MBL) Company Information
 Table 91. JSR Life Sciences (MBL) Description and Business Overview
 Table 92. JSR Life Sciences (MBL) In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. JSR Life Sciences (MBL) In Vitro Diagnostic Active Ingredients Product
 Table 94. JSR Life Sciences (MBL) Recent Developments/Updates
 Table 95. HyTest Company Information
 Table 96. HyTest Description and Business Overview
 Table 97. HyTest In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. HyTest In Vitro Diagnostic Active Ingredients Product
 Table 99. HyTest Recent Developments/Updates
 Table 100. BBI Solution Company Information
 Table 101. BBI Solution Description and Business Overview
 Table 102. BBI Solution In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BBI Solution In Vitro Diagnostic Active Ingredients Product
 Table 104. BBI Solution Recent Developments/Updates
 Table 105. Meridian Company Information
 Table 106. Meridian Description and Business Overview
 Table 107. Meridian In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Meridian In Vitro Diagnostic Active Ingredients Product
 Table 109. Meridian Recent Developments/Updates
 Table 110. Biosynth Company Information
 Table 111. Biosynth Description and Business Overview
 Table 112. Biosynth In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Biosynth In Vitro Diagnostic Active Ingredients Product
 Table 114. Biosynth Recent Developments/Updates
 Table 115. Creative Diagnostics Company Information
 Table 116. Creative Diagnostics Description and Business Overview
 Table 117. Creative Diagnostics In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Creative Diagnostics In Vitro Diagnostic Active Ingredients Product
 Table 119. Creative Diagnostics Recent Developments/Updates
 Table 120. Leinco Technologies Company Information
 Table 121. Leinco Technologies Description and Business Overview
 Table 122. Leinco Technologies In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Leinco Technologies In Vitro Diagnostic Active Ingredients Product
 Table 124. Leinco Technologies Recent Developments/Updates
 Table 125. SERION Immunologics Company Information
 Table 126. SERION Immunologics Description and Business Overview
 Table 127. SERION Immunologics In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. SERION Immunologics In Vitro Diagnostic Active Ingredients Product
 Table 129. SERION Immunologics Recent Developments/Updates
 Table 130. MP Biomedicals Company Information
 Table 131. MP Biomedicals Description and Business Overview
 Table 132. MP Biomedicals In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. MP Biomedicals In Vitro Diagnostic Active Ingredients Product
 Table 134. MP Biomedicals Recent Developments/Updates
 Table 135. Autobio Diagnostics Company Information
 Table 136. Autobio Diagnostics Description and Business Overview
 Table 137. Autobio Diagnostics In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Autobio Diagnostics In Vitro Diagnostic Active Ingredients Product
 Table 139. Autobio Diagnostics Recent Developments/Updates
 Table 140. Fapon Biotech Company Information
 Table 141. Fapon Biotech Description and Business Overview
 Table 142. Fapon Biotech In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Fapon Biotech In Vitro Diagnostic Active Ingredients Product
 Table 144. Fapon Biotech Recent Developments/Updates
 Table 145. Sino Biological Company Information
 Table 146. Sino Biological Description and Business Overview
 Table 147. Sino Biological In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Sino Biological In Vitro Diagnostic Active Ingredients Product
 Table 149. Sino Biological Recent Developments/Updates
 Table 150. Nanjing Vazyme Biotech Company Information
 Table 151. Nanjing Vazyme Biotech Description and Business Overview
 Table 152. Nanjing Vazyme Biotech In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Nanjing Vazyme Biotech In Vitro Diagnostic Active Ingredients Product
 Table 154. Nanjing Vazyme Biotech Recent Developments/Updates
 Table 155. GenScript ProBio Company Information
 Table 156. GenScript ProBio Description and Business Overview
 Table 157. GenScript ProBio In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. GenScript ProBio In Vitro Diagnostic Active Ingredients Product
 Table 159. GenScript ProBio Recent Developments/Updates
 Table 160. OPERON Company Information
 Table 161. OPERON Description and Business Overview
 Table 162. OPERON In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. OPERON In Vitro Diagnostic Active Ingredients Product
 Table 164. OPERON Recent Developments/Updates
 Table 165. ABclonal Company Information
 Table 166. ABclonal Description and Business Overview
 Table 167. ABclonal In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. ABclonal In Vitro Diagnostic Active Ingredients Product
 Table 169. ABclonal Recent Developments/Updates
 Table 170. BioPorto Company Information
 Table 171. BioPorto Description and Business Overview
 Table 172. BioPorto In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. BioPorto In Vitro Diagnostic Active Ingredients Product
 Table 174. BioPorto Recent Developments/Updates
 Table 175. Glentham Life Sciences Company Information
 Table 176. Glentham Life Sciences Description and Business Overview
 Table 177. Glentham Life Sciences In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Glentham Life Sciences In Vitro Diagnostic Active Ingredients Product
 Table 179. Glentham Life Sciences Recent Developments/Updates
 Table 180. ImmunoDiagnostics Company Information
 Table 181. ImmunoDiagnostics Description and Business Overview
 Table 182. ImmunoDiagnostics In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. ImmunoDiagnostics In Vitro Diagnostic Active Ingredients Product
 Table 184. ImmunoDiagnostics Recent Developments/Updates
 Table 185. Prahas Healthcare Company Information
 Table 186. Prahas Healthcare Description and Business Overview
 Table 187. Prahas Healthcare In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Prahas Healthcare In Vitro Diagnostic Active Ingredients Product
 Table 189. Prahas Healthcare Recent Developments/Updates
 Table 190. Promega Company Information
 Table 191. Promega Description and Business Overview
 Table 192. Promega In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. Promega In Vitro Diagnostic Active Ingredients Product
 Table 194. Promega Recent Developments/Updates
 Table 195. Rockland Immunochemicals Company Information
 Table 196. Rockland Immunochemicals Description and Business Overview
 Table 197. Rockland Immunochemicals In Vitro Diagnostic Active Ingredients Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 198. Rockland Immunochemicals In Vitro Diagnostic Active Ingredients Product
 Table 199. Rockland Immunochemicals Recent Developments/Updates
 Table 200. Key Raw Materials Lists
 Table 201. Raw Materials Key Suppliers Lists
 Table 202. In Vitro Diagnostic Active Ingredients Distributors List
 Table 203. In Vitro Diagnostic Active Ingredients Customers List
 Table 204. In Vitro Diagnostic Active Ingredients Market Trends
 Table 205. In Vitro Diagnostic Active Ingredients Market Drivers
 Table 206. In Vitro Diagnostic Active Ingredients Market Challenges
 Table 207. In Vitro Diagnostic Active Ingredients Market Restraints
 Table 208. Research Programs/Design for This Report
 Table 209. Key Data Information from Secondary Sources
 Table 210. Key Data Information from Primary Sources
 Table 211. Authors List of This Report


List of Figures
 Figure 1. Product Picture of In Vitro Diagnostic Active Ingredients
 Figure 2. Global In Vitro Diagnostic Active Ingredients Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global In Vitro Diagnostic Active Ingredients Market Share by Type: 2024 & 2031
 Figure 4. Monoclonal Antibodies Product Picture
 Figure 5. Polyclonal Antibodies Product Picture
 Figure 6. Recombinant Antibodies Product Picture
 Figure 7. Global In Vitro Diagnostic Active Ingredients Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global In Vitro Diagnostic Active Ingredients Market Share by Application: 2024 & 2031
 Figure 9. Diabetes
 Figure 10. Infectious Diseases
 Figure 11. Oncology
 Figure 12. Heart Disease
 Figure 13. Others
 Figure 14. Global In Vitro Diagnostic Active Ingredients Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global In Vitro Diagnostic Active Ingredients Market Size (2020-2031) & (US$ Million)
 Figure 16. Global In Vitro Diagnostic Active Ingredients Sales (2020-2031) & (Units)
 Figure 17. Global In Vitro Diagnostic Active Ingredients Average Price (US$/Unit) & (2020-2031)
 Figure 18. In Vitro Diagnostic Active Ingredients Report Years Considered
 Figure 19. In Vitro Diagnostic Active Ingredients Sales Share by Manufacturers in 2024
 Figure 20. Global In Vitro Diagnostic Active Ingredients Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest In Vitro Diagnostic Active Ingredients Players: Market Share by Revenue in In Vitro Diagnostic Active Ingredients in 2024
 Figure 22. In Vitro Diagnostic Active Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global In Vitro Diagnostic Active Ingredients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America In Vitro Diagnostic Active Ingredients Sales Market Share by Country (2020-2031)
 Figure 25. North America In Vitro Diagnostic Active Ingredients Revenue Market Share by Country (2020-2031)
 Figure 26. United States In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe In Vitro Diagnostic Active Ingredients Sales Market Share by Country (2020-2031)
 Figure 29. Europe In Vitro Diagnostic Active Ingredients Revenue Market Share by Country (2020-2031)
 Figure 30. Germany In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific In Vitro Diagnostic Active Ingredients Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific In Vitro Diagnostic Active Ingredients Revenue Market Share by Region (2020-2031)
 Figure 37. China In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America In Vitro Diagnostic Active Ingredients Sales Market Share by Country (2020-2031)
 Figure 45. Latin America In Vitro Diagnostic Active Ingredients Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa In Vitro Diagnostic Active Ingredients Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa In Vitro Diagnostic Active Ingredients Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE In Vitro Diagnostic Active Ingredients Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of In Vitro Diagnostic Active Ingredients by Type (2020-2031)
 Figure 56. Global Revenue Market Share of In Vitro Diagnostic Active Ingredients by Type (2020-2031)
 Figure 57. Global In Vitro Diagnostic Active Ingredients Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of In Vitro Diagnostic Active Ingredients by Application (2020-2031)
 Figure 59. Global Revenue Market Share of In Vitro Diagnostic Active Ingredients by Application (2020-2031)
 Figure 60. Global In Vitro Diagnostic Active Ingredients Price (US$/Unit) by Application (2020-2031)
 Figure 61. In Vitro Diagnostic Active Ingredients Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Foetal Skull Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8G20187
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Anatomy Set Pregnancy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30J19782
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Embryo Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39D19945
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Prostate Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25M19897
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions